GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV ...

Healgen Scientific LLC, a leading innovator in diagnostic solutions, announced the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization for Healgen Rapid Check® COVID-19 ...

Boston IVF is pleased to announce the addition of reproductive endocrinologist, Dr. Riwa Sabbagh to its new fertility center in Concord, Massachusetts. Dr. Sabbagh's arrival enhances Boston IVF's ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

RSV vaccine sales by GSK and Pfizer have dropped in the U.S. after regulators limited the eligible age group, affecting ...

The Netherlands will add the jab against the respiratory syncytial virus (RS virus) to the National Vaccination Program next ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

The Allegheny County Health Department launched a new respiratory virus dashboard Monday. Residents can use the tool to find ...

RSV rates can be expected to increase, and flu, as well as other common viruses. Human metapneumovirus tends to peak in ...

The RSV vaccines have gone through extensive testing. Last year, more than 20 million older adults were vaccinated safely.

DPX™-RSV for Respiratory Syncytial Virus, and BVX-0918, a personalized immunotherapeutic vaccine using its proprietary HapTenix© "neoantigen" tumor cell construct platform for refractive late-stage ...